CAS 1661854-97-2

Zipalertinib

CAS: 1661854-97-2

Formel: C₂₃H₂₀N₆O

Reinheit: 97%

Farbe und Form: Solid

Molekulargewicht: 396.4445

Ref: IN-DA01EO8V

N-[(8S)-4-Amino-6-Methyl-5-Quinolin-3-Yl-8,9-Dihydropyrimido[5,4-b]Indolizin-8-Yl]Prop-2-Enamide

CAS: 1661854-97-2

N-[(8S)-4-Amino-6-Methyl-5-Quinolin-3-Yl-8,9-Dihydropyrimido[5,4-b]Indolizin-8-Yl]Prop-2-Enamide

Formel: C₂₃H₂₀N₆O

Reinheit: 97%

Molekulargewicht: 396.4

Ref: 54-OR1024053

TAS6417

CAS: 1661854-97-2

TAS6417

Formel: C₂₃H₂₀N₆O

Reinheit: ≥98%

Molekulargewicht: 396.44

Ref: 54-BUP12830

TAS6417

CAS: 1661854-97-2

Zipalertinib (TAS6417, CLN-081) is a novel, highly potent, orally active covalent EGFR tyrosine kinase inhibitor.Cost-effective and quality-assured.

Formel: C₂₃H₂₀N₆O

Reinheit: 99.71% - 99.85%

Farbe und Form: Solid

Molekulargewicht: 396.44

Ref: TM-T16996

TAS 6417

CAS: 1661854-97-2

Inhibits mutated EGFR with exon 20 insertion; anti-cancer agent

Formel: C₂₃H₂₀N₆O

Reinheit: Min. 95%

Molekulargewicht: 396.44 g/mol

Ref: 3D-FT166464